RESEARCH TRIANGLE PARK, NORTH CAROLINA–(Marketwired – Nov. 13, 2014) – • SIOPEL 6 Has Enrolled 112 Patients With Study Completion Expected by Year End • Safety Data on 100 Patients Expected During Q1 2015 • Name Change, Warrant Exchange and Share Consolidation Completed Fennec Pharmaceuticals Inc. (TSX:FRX)(OTCQB:FENCF) today reported its financial results and recent developments […]
Category: Press Releases
FENNEC PHARMACEUTICALS ANNOUNCES OVER THE COUNTER TRADING SYMBOL CHANGE
RESEARCH TRIANGLE PARK, NC, Sept. 5, 2014 – Fennec Pharmaceuticals Inc. (TSX: FRX; OTC: ADHXD) (the “Company”) formerly known as Adherex Technologies Inc., today announced that the Financial Industry Regulatory Authority (“FINRA”) has approved the Company’s corporate actions regarding its previously announced name change and share consolidation. As of open of business on September 5, […]
Read More… from FENNEC PHARMACEUTICALS ANNOUNCES OVER THE COUNTER TRADING SYMBOL CHANGE
ADHEREX ANNOUNCES SHARE CONSOLIDATION, NAME CHANGE AND TRADING SYMBOL CHANGE
RESEARCH TRIANGLE PARK, NC, Sept. 3, 2014 – Adherex Technologies Inc. (TSX: AHX; OTC: ADHXF) (the “Company”) announced today that it gave effect to the consolidation of its outstanding share capital on the basis of one new security for every three outstanding securities (the “Consolidation”). In addition, the Company filed a Notice of Alteration with […]
Read More… from ADHEREX ANNOUNCES SHARE CONSOLIDATION, NAME CHANGE AND TRADING SYMBOL CHANGE
ADHEREX PROVIDES CORPORATE UPDATE AND SECOND QUARTER ENDED JUNE 30, 2014 FINANCIAL RESULTS
August 11, 2014 Research Triangle Park, NC, August 11, 2014 – – Adherex Technologies Inc. (TSX: AXH, OTCQB: ADHXF), today reported its financial results and recent developments for the second quarter ended June 30, 2014. All amounts are in US dollars unless otherwise specified. As reported during the second quarter, the results from two Phase […]
ADHEREX ANNOUNCES WARRANT EXCHANGE RESULTS AND NEW CAPITAL STRUCTURE
Research Triangle Park, NC, August 8, 2014 – – Adherex Technologies Inc. (TSX: AXH, OTCQB: ADHXF), today reported the final results of the Warrant exchange which concluded on July 29, 2014. Approximately, 71% of all outstanding warrants originally issued by the Company on April 30, 2010 and 48% of all outstanding warrants issued on March 29, 2011 participated in the exchange. […]
Read More… from ADHEREX ANNOUNCES WARRANT EXCHANGE RESULTS AND NEW CAPITAL STRUCTURE
ADHEREX TECHNOLOGIES INC. ANNOUNCES WARRANT EXCHANGE
RESEARCH TRIANGLE PARK, NC, June 30, 2014 – Adherex Technologies Inc. (TSX: AHX; OTC: ADHXF) (the “Company”) today announced it is offering holders of warrants originally issued by the Company on or about April 30, 2010 and March 29, 2011 the opportunity to exchange 180 warrants for one new warrant to purchase one share of […]
Read More… from ADHEREX TECHNOLOGIES INC. ANNOUNCES WARRANT EXCHANGE
ADHEREX ANNOUNCES RESULTS FROM TWO SODIUM THIOSULFATE PHASE 3 STUDIES PRESENTED AT THE 50TH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
–COG STUDY ACCL0431 meets primary endpoint for prevention of cisplatin-induced hearing loss in children -SIOPEL 6 Data Monitoring Committee recommends continuation of study after safety review of 80 standard risk hepatoblastoma patients Research Triangle Park, NC — June 2, 2014 – Adherex Technologies, Inc. (TSX: AHX, OTC: ADHXF) today announced the results on the […]
Adherex Announces Results of Annual and Special Meeting
Research Triangle Park, NC — (Marketwire) – May 30, 2014 – Adherex Technologies Inc. (TSX:AHX, OTC: ADHXF) today announced that the nominees listed in the management proxy circular dated April 28,2014 (the “Circular”) for the Annual and Special Meeting of Shareholders were elected as directors of the Company at the Annual and Special Meeting of […]
Read More… from Adherex Announces Results of Annual and Special Meeting
Adherex Responds to Trading Activity
Research Triangle Park, NC — (Marketwire) – May 27, 2014 – Adherex Technologies Inc. (TSX:AHX, OTC: ADHXF) is responding to a request from the Investment Industry Regulatory Organization of Canada on behalf of the Toronto Stock Exchange following recent trading activity. Ordinarily, the Company’s policy is not to comment on rumors or speculation. Adherex is […]
ADHEREX PROVIDES CORPORATE UPDATE AND FIRST QUARTER ENDED MARCH 31, 2014 FINANCIAL RESULTS
Research Triangle Park, NC, May 15, 2014 – – Adherex Technologies Inc. (TSX: AXH, OTCQB: ADHXF), today reported its financial results and recent developments for the first quarter ended March 31, 2014. All amounts are in US dollars unless otherwise specified. As reported, the two Phase 3 clinical trials studying Sodium Thiosulfate (STS) for […]